Bedside Ultrasonography in Acute Patients With Suspected Kidney Involvement

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03873701

Enrollment

153

Registered

2019-03-13

Start date

2018-11-02

Completion date

2019-04-08

Last updated

2019-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydronephrosis, Pyelonephritis, Urosepsis

Keywords

bedside ultrasonography, emergency department

Brief summary

The aim of this study is to evaluate the accuracy and implications of the diagnoses and treatment determined by bedside ultrasonography (b-US) of the kidneys compared to current clinical assessment. Potentially diagnosing patients faster and avoiding missing conditions leading to readmission or unnecessary radiation from computed tomography (CT). This study evaluates the use of b-US as a supplement to clinical evaluation, in an unselected group of patients in the emergency department (ED) with signs of kidney involvement. The b-US of the kidneys is performed by a medical student certified in this technique. The evaluation will be based on data collected from a Danish hospital (Odense University Hospital, OUH) in autumn 2018.

Interventions

DIAGNOSTIC_TESTbedside ultrasonography

Patients suspicious to urinary tract infection with kidney involvement are being examined by ultrasonography to detect hydroneprhosis. The treating clinicians fill out questionnaires to validate the impact of the bedside ultrasonography on the patient care and treatment.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Suspicion of urinary tract infection and one or more of the following: * Flank pain * Fever * Symptoms when voiding * Creatinine elevation or 20% elevation from known creatinine level elevation

Exclusion criteria

* Age \< 18 years * Radiological ultrasonographic examination already performed * Patients who are not able to consent

Design outcomes

Primary

Measure	Time frame	Description
Ultrasonographic hydronephrosis	All included patient undergo bedside ultrasonography within 4 hours after admission	Ultrasonographic hydronephrosis defined by \> 1cm pelvic dilation

Secondary

Measure	Time frame	Description
Clinical consequence of bedside ultrasonographic result	Within 4 hours after admission	Clinicians responsible for the primary clinical assessment determine treatment and further examinations before and after the ultrasonographic results.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026